Tandem Diabetes Care, Inc. (TNDM)
20.09
-0.34
(-1.66%)
USD |
NASDAQ |
Sep 04, 12:26
Tandem Diabetes Care Research and Development Expense (TTM) : 186.91M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 186.91M |
| March 31, 2026 | 188.10M |
| December 31, 2025 | 192.28M |
| September 30, 2025 | 198.42M |
| June 30, 2025 | 201.64M |
| March 31, 2025 | 202.85M |
| December 31, 2024 | 198.88M |
| September 30, 2024 | 189.28M |
| June 30, 2024 | 180.14M |
| March 31, 2024 | 173.75M |
| December 31, 2023 | 169.67M |
| September 30, 2023 | 162.65M |
| June 30, 2023 | 188.49M |
| March 31, 2023 | 179.13M |
| December 31, 2022 | 170.13M |
| September 30, 2022 | 164.04M |
| June 30, 2022 | 120.33M |
| March 31, 2022 | 107.25M |
| December 31, 2021 | 92.06M |
| September 30, 2021 | 79.94M |
| June 30, 2021 | 71.93M |
| March 31, 2021 | 67.42M |
| December 31, 2020 | 63.57M |
| September 30, 2020 | 58.76M |
| June 30, 2020 | 54.71M |
| Date | Value |
|---|---|
| March 31, 2020 | 49.93M |
| December 31, 2019 | 45.20M |
| September 30, 2019 | 41.43M |
| June 30, 2019 | 37.39M |
| March 31, 2019 | 32.64M |
| December 31, 2018 | 29.23M |
| September 30, 2018 | 26.18M |
| June 30, 2018 | 23.10M |
| March 31, 2018 | 21.51M |
| December 31, 2017 | 20.66M |
| September 30, 2017 | 19.25M |
| June 30, 2017 | 20.49M |
| March 31, 2017 | 19.77M |
| December 31, 2016 | 18.81M |
| September 30, 2016 | 18.60M |
| June 30, 2016 | 17.54M |
| March 31, 2016 | 17.27M |
| December 31, 2015 | 16.96M |
| September 30, 2015 | 16.75M |
| June 30, 2015 | 16.17M |
| March 31, 2015 | 15.99M |
| December 31, 2014 | 15.79M |
| September 30, 2014 | 15.22M |
| June 30, 2014 | 13.36M |
| March 31, 2014 | 12.42M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| DexCom, Inc. | 604.00M |
| Modular Medical, Inc. | 17.45M |
| Senseonics Holdings, Inc. | 36.83M |
| NeuroPace, Inc. | 27.69M |
| Abbott Laboratories | 3.128B |